메뉴 건너뛰기




Volumn 185, Issue 9, 2012, Pages 1015-1020

Improving outcomes for pulmonary vascular disease

Author keywords

Clinical trials; Pediatrics; Pulmonary hypertension; Pulmonary vascular changes

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTANOID; WARFARIN;

EID: 84860643158     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201201-0049WS     Document Type: Conference Paper
Times cited : (21)

References (11)
  • 2
  • 5
    • 79955383532 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension associated with systemic sclerosis
    • Mathai SC, Hassoun PM. Pulmonary arterial hypertension associated with systemic sclerosis. Expert Rev Respir Med 2011;5:267-279.
    • (2011) Expert Rev Respir Med , vol.5 , pp. 267-279
    • Mathai, S.C.1    Hassoun, P.M.2
  • 6
    • 0023615359 scopus 로고
    • Primary pulmonary hypertension. A national prospective study
    • Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-223. (Pubitemid 17137857)
    • (1987) Annals of Internal Medicine , vol.107 , Issue.2 , pp. 216-223
    • Rich, S.1    Dantzker, D.R.2    Ayres, S.M.3
  • 8
    • 62249199804 scopus 로고    scopus 로고
    • Treatment and survival in children with pulmonary arterial hypertension: The UK Pulmonary Hypertension Service for Children 2001-2006
    • Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006. Heart 2009;95:312-317.
    • (2009) Heart , vol.95 , pp. 312-317
    • Haworth, S.G.1    Hislop, A.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.